The most significant variation of BRCA1 expression was obtained in contact with the GFAP + PTX scaffold (p < 0.01), suggesting that the composition of GFAP promotes PTX activity with the highest efficiency in breast tumor cells. The gene discussed is BRCA1; the disease is breast neoplasm.